Insider Transactions in Q2 2023 at Science 37 Holdings, Inc. (SNCE)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 19
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,614
-0.77%
|
-
|
May 19
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+2.24%
|
-
|
May 11
2023
|
Robert C. Faulkner |
BUY
Grant, award, or other acquisition
|
Direct |
494,853
+48.01%
|
$0
$0.25 P/Share
|
May 11
2023
|
Redmile Group, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
494,853
+2.37%
|
$0
$0.25 P/Share
|
May 11
2023
|
Neil Tiwari |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
May 11
2023
|
Emily Rollins |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
May 11
2023
|
John W Hubbard |
BUY
Exercise of conversion of derivative security
|
Direct |
40,983
+50.0%
|
-
|
May 11
2023
|
Paul Von Autenried |
BUY
Exercise of conversion of derivative security
|
Direct |
46,040
+50.0%
|
-
|
Apr 28
2023
|
Jonathan Cotliar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
257,320
+21.42%
|
-
|
Apr 28
2023
|
Darcy Forman Chief Delivery Officer |
BUY
Grant, award, or other acquisition
|
Direct |
492,916
+44.96%
|
-
|
Apr 28
2023
|
Christine A Pellizzari Chief Legal and HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
702,332
+49.73%
|
-
|
Apr 28
2023
|
Mike Zaranek Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
444,283
+50.0%
|
-
|
Apr 28
2023
|
David Coman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
615,650
+31.45%
|
-
|